Dyfyniad APA

Mohedas, A., Wang, Y., Sanvitale, C., Canning, P., Choi, S., Xing, X., . . . Yu, P. (2014). Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.

Dyfyniad Arddull Chicago

Mohedas, A., Y. Wang, C. Sanvitale, P. Canning, S. Choi, X. Xing, A. Bullock, G. Cuny, and P. Yu. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.

Dyfyniad MLA

Mohedas, A., et al. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.